Venture Round - ENTEROME
Investment Firm
Overview
Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.
Announced Date
Oct 30, 2023
Funding Type
Series Unknown
Highlights
Location
Europe
Social
Investor Lead
N/A
Participant Investors
1
No investment info available on this profile
Round Details and Background
ENTEROME raised $3184179 on 2023-10-30 in Venture Round
Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.
Company Funding History
9
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Oct 30, 2023 |  Venture Round - ENTEROME | 1 | - | 3.2M |
| Apr 20, 2016 | Series C - ENTEROME | 5 | - | 16.4M |
| May 01, 2014 | Series B - ENTEROME | 3 | - | 15.3M |
| Mar 23, 2012 | Series A - ENTEROME | 4 | - | 9.9M |
Recent Activity
There is no recent news or activity for this profile.